Acadia Pharmaceuticals
ACAD
ACAD
222 hedge funds and large institutions have $2.48B invested in Acadia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 81 increasing their positions, 66 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.72% more ownership
Funds ownership: 93.46% → 94.18% (+0.72%)
9% less funds holding
Funds holding: 245 → 222 (-23)
50% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 46
Holders
222
Holding in Top 10
4
Calls
$11.2M
Puts
$7.41M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$15.5M | |
| 3 | +$14M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$12.2M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$11.5M |
Top Sellers
| 1 | -$24.4M | |
| 2 | -$13.5M | |
| 3 | -$10.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$9.16M |
| 5 |
RI
RTW Investments
New York
|
-$9.05M |